MyHealthChecked issues new shares after options exercise Via Investing.com
LONDON – MyHealthChecked PLC (AIM: MHC), a UK consumer home check company, has announced the issue of 30,000 new ordinary shares following the exercise of options. The shares, each with a nominal value of 1.5p, were allotted on Monday, December 20, 2024, under the company’s existing mandate.
The options are exercised at a price of 9.5 pence per share. The new ordinary shares are expected to be admitted to trading London Stock Exchange (LON:)’s AIM market at 8.00 am on or about 31 December 2024, and will rank equally in all respects with the company’s existing ordinary shares.
After the adoption of the new shares, the total issued capital of MyHealthChecked will consist of 52,035,932 common shares. As a result, the total number of voting rights in the company will be 52,035,932, which the shareholders can use as a minimum value in the calculation related to their profit notifications under the Financial Authority’s Disclosure Directive and Transparency Laws.
MyHealthChecked specializes in a variety of home health care and wellness assessments. Their portfolio includes lateral-flow self-testing and sample collection kits for DNA, RNA, and blood, which are analyzed by our partner laboratories. These products aim to cater to the growing market of consumers looking for affordable healthcare options.
The company has made its products available online and to buy over the counter, positioning itself within the growing home test kit market emphasizing the affordability and expertise of UK professionals.
This development is based on a press release and reflects the company’s ongoing efforts to manage its equity capital effectively. The information provided does not constitute an endorsement of the company’s market position or future prospects.
This article was created with the support of AI and reviewed by an editor. For more information see our T&C.
